您的位置: 首页 > 农业专利 > 详情页

PHARMACEUTICAL COMPOSITION FOR TREATING FLT3 MUTATION POSITIVE CANCER FLT3 MUTANT INHIBITOR AND USE OF SAID PHARMACEUTICAL COMPOSITION AND SAID INHIBITOR
专利权人:
发明人:
NAOE TOMOKI,KIYOI HITOSHI,HAGIWARA SHINJI,TAKASAKI MASARU,HIRANO DAISUKE,NAKATANI TOSHIYUKI,YAMAURA TAKESHI
申请号:
IN201747005498
公开号:
IN201747005498A
申请日:
2017.02.16
申请国别(地区):
IN
年份:
2017
代理人:
摘要:
The present invention addresses the problem of providing: a pharmaceutical composition for treating FLT3 mutation positive cancer; an FLT3 mutant inhibitor; and a use of the pharmaceutical composition and the inhibitor. Provided are: a pharmaceutical composition for treating FLT3 mutation positive cancer which contains as an active ingredient a compound represented by general formula [1] or a salt thereof; an FLT3 mutant inhibitor; an anti cancer agent; a method for predicting the therapeutic effect of the administration of a pharmaceutical composition containing a compound represented by general formula [1] or a salt thereof in a subject said method comprising a step of detecting the presence or absence of an FLT3 mutation; a method for selecting a subject to whom a pharmaceutical composition containing a compound represented by general formula [1] or a salt thereof can be applied said method comprising a step of detecting the presence or absence of an FLT3 mutation; and a method for determining whether or not a pharmaceutical composition containing a compound represented by general formula [1] or a salt thereof can be administered to a subject said method comprising a step of detecting the presence or absence of an FLT3 mutation.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充